Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
AstraZeneca strikes $1.2bn obesity drug deal with China's CSPC
02:35am, Friday, 30'th Jan 2026
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is paying $1.2 billion up-front to seal a tie-up with a Chinese pharma giant aimed at expanding its weight-loss drug pipeline, as it looks to compete in a fast-g
World leaders descend on Beijing as 2026 kicks off, hedging against U.S. disruptions
02:15am, Friday, 30'th Jan 2026
At least five world leaders have visited Beijing in January alone. The high-level visits come as countries navigate tense U.S. relations.
China's CSPC Pharmaceutical inks deal with AstraZeneca for weight loss therapy
08:35pm, Thursday, 29'th Jan 2026
CSPC Pharmaceutical Group said on Friday it had entered an agreement with UK drugmaker AstraZeneca for the development of innovative long-acting peptide medicines for obesity and weight-related condit
AstraZeneca sets out $15 billion China investment during Starmer visit
05:00am, Thursday, 29'th Jan 2026
UK drugmaker AstraZeneca said on Thursday it would invest $15 billion in China through 2030 to expand medicines manufacturing and research and development, an announcement made during British Prime Mi
University of Virginia Signs Master Research Collaboration Agreement with AstraZeneca to Accelerate Pre-Clinical Innovation
04:01pm, Wednesday, 28'th Jan 2026
Agreement builds on long-established partnership and demonstrates the strength and importance of industry/academic scientific collaborations Agreement builds on long-established partnership and demons
Airbus, AstraZeneca and HSBC executives join UK's Starmer on high-stakes China trip
10:59pm, Tuesday, 27'th Jan 2026
Starmer brings nearly 60 business and cultural groups on first U.K. leader visit to China in eight years. Talks with Xi and Li focus on trade, investment and national security.
FTSE 100 Live: London stocks climb as HSBC becomes largest company
10:01am, Tuesday, 27'th Jan 2026
FTSE 100 climbs 55 points to 10,205 HSBC becomes largest company in index Dr Martens sales slowdown disappoints William Hill owner Evoke reports strongest...
AstraZeneca the 'top pick' among European pharmas - broker
08:33am, Tuesday, 27'th Jan 2026
Analysts at Citi see AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) as 'the top pick' among European pharmaceutical firms. and rate the FTSE 100 stock as a 'buy'.
AstraZeneca the 'top pick' among European pharmas - broker
08:15am, Tuesday, 27'th Jan 2026
Analysts at Citi see AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) as 'the top pick' among European pharmaceutical firms'. The FTSE 100 drugmaker is forecast by...
FTSE 100 Live: London stocks climb with HSBC taking crown as largest company
08:02am, Tuesday, 27'th Jan 2026
FTSE 100 climbs 46 points to 10,195 HSBC becomes largest company in index Dr Martens sales slowdown disappoints William Hill owner Evoke reports strongest...
Chilton Capital Management LLC Has $30.99 Million Holdings in AstraZeneca PLC $AZN
05:02am, Tuesday, 27'th Jan 2026
Chilton Capital Management LLC boosted its stake in AstraZeneca PLC (NASDAQ: AZN) by 1.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
Biotech Veteran and Virologist Joins CancerVax as Senior Scientific Advisor
03:00am, Tuesday, 27'th Jan 2026
Dr. George Kemble, former AstraZeneca executive, to advise the Company on immunological and viral strategies for its novel cancer treatment platform Dr. George Kemble, former AstraZeneca executive, to
Why Astrazeneca (AZN) Outpaced the Stock Market Today
07:15pm, Monday, 26'th Jan 2026
Astrazeneca (AZN) closed at $94.23 in the latest trading session, marking a +1.38% move from the prior day.
Envestnet Portfolio Solutions Inc. Sells 8,549 Shares of AstraZeneca PLC $AZN
03:58am, Monday, 26'th Jan 2026
Envestnet Portfolio Solutions Inc. lessened its holdings in shares of AstraZeneca PLC (NASDAQ: AZN) by 13.8% in the third quarter, according to the company in its most recent disclosure with the Secur
AstraZeneca PLC $AZN Shares Acquired by Arkadios Wealth Advisors
03:34am, Saturday, 24'th Jan 2026
Arkadios Wealth Advisors increased its position in shares of AstraZeneca PLC (NASDAQ: AZN) by 62.6% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange C
